| 摘要 |
The invention relates to a novel heparin having an average molecular weight within a range of from 10 to 11.5 kd, in particular, an average molecular weight of 10 kd. Said heparin is obtained by controlled depolymerization of unfractionated heparin and subsequent molecular filtration. Said heparin is used for the preparation of a medicament for the prophylaxis and therapy of thrombo-embolic processes and, inter alia, for the inhibition of coagulation in extracorporeal circulations.
|
